Re: Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms that Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

✍ Scribed by Mario A. Eisenberger

• Book ID: 113611120
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 101 KB
• Volume: 55
• Category: Article
• ISSN: 0302-2838
• DOI: 10.1016/j.eururo.2008.09.035